Boe Sorensen

Title: Boe Sorensen: Innovator in Cancer Monitoring Technologies

Introduction

Boe Sorensen is a notable inventor based in Beder, Denmark. He has made significant contributions to the field of cancer monitoring through his innovative patents. With a total of two patents to his name, Sorensen's work focuses on improving methods for assessing the status of solid-tumor cancers.

Latest Patents

Sorensen's latest patents include advancements in EGFR blood monitoring and mutation testing. The EGFR blood monitoring patent presents improved methods for assessing the status of solid-tumor cancer in a subject by detecting tumor-associated mutations in the subject's blood. Similarly, his mutation testing patent enhances the methods for evaluating the status of solid tumor cancer through the detection of these mutations.

Career Highlights

Throughout his career, Sorensen has worked with prominent organizations such as Roche Molecular Systems, Inc. and Aarhus University. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer monitoring.

Collaborations

Some of Sorensen's notable coworkers include Peter Meldgaard and Julie Tsai. Their collaboration has contributed to the advancement of cancer research and monitoring technologies.

Conclusion

Boe Sorensen's contributions to cancer monitoring through his patents and collaborations highlight his role as an innovator in the field. His work continues to impact the assessment of solid-tumor cancers, paving the way for improved patient outcomes.